Meeting registration will close on January 31, 2020 for the U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity. The meeting will be held Feb 25-26, 2020 at the NIAID Conference Center in Rockville, Md. The meeting is sponsored by the Chemical Countermeasures Research Program (CCRP),
CEPI has opened a call for proposals to rapidly develop and manufacture a proven vaccine approach that can be used against 2019-nCoV. The call is open for two weeks until mid-February. Applications are open worldwide to all types of non-profit research organisations, for-profit companies, international organisations and foundations, joint R&D ventures, government research organisations, and
The capability to provide unburdened chem-bio protection will maximize time on target for the warfighter and the stability operator, provide operational flexibility, extend mission duration, and enable military operations in austere environments regardless of the threat. PPB will consist of lightweight materials that protect the warfighter from exposure to any CB threat while simultaneously providing
HHS-NIH-NIAID-BAA2020-1 Research Area 002: Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis (AFM) Associated With Enterovirus D68 Supports the development of inactivated Enterovirus D68 vaccines, preferably using adjuvants that minimize regulatory concerns and expedite vaccine development into a Phase I clinical trial. Due Date: February 28, 2020, by 3 p.m. Eastern Time Learn more
